proxyvotesnow.com

Home › Asset managers › ProShares › 2025-2026 › Against the board

ProShares 2025-2026: where it broke with the board

Two kinds of vote are listed: a board-sponsored proposal ProShares voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.

Everything Only shareholder proposals it backed

2,875 proposals.

ProShares, 2025-2026 proxy season. Who put a proposal on the ballot is taken from the filer’s own N-PX answer (Item 1(h)), or, marked “inferred”, from its category and wording where the filing does not say; see how we count these.
CompanyMeetingProposalCategory On the ballot fromBoard recommendedProShares votedFunds
First Citizens BancShares, Inc. May 4, 2026 Election of 12 directors for one-year terms: Robert T. Newcomb Director Elections Board WITHHOLD 2
First Citizens BancShares, Inc. May 4, 2026 Election of 12 directors for one-year terms: Victor E. Bell III Director Elections Board WITHHOLD 2
GDS Holdings Limited March 10, 2026 Amend Articles of Association to Increase Voting Power Attached to Class B Ordinary Shares Held by William Wei Huang Capital Structure Board AGAINST 2
GDS Holdings Limited June 25, 2026 Amend Omnibus Stock Plan Compensation Board AGAINST 2
GDS Holdings Limited June 25, 2026 Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure Board AGAINST 2
Global-e Online Ltd. May 11, 2026 Approve Amended Compensation Terms of Company Co-Founders Compensation Board AGAINST 2
Global-e Online Ltd. May 11, 2026 Approve Amended and Restated Compensation Policy for the Directors and Officers of the Company Compensation Board AGAINST 2
Iberdrola SA May 29, 2026 Approve Long-Term Incentive Plan Compensation Board AGAINST 2
Kanzhun Limited June 25, 2026 Approve PricewaterhouseCoopers and PricewaterhouseCoopers Zhong Tian LLP as Auditors and Authorize Board to Fix Their Remuneration Audit-related Board AGAINST 2
Kingsoft Cloud Holdings Limited June 30, 2026 Adopt 2026 Share Incentive Plan Compensation Board AGAINST 2
Kingsoft Cloud Holdings Limited June 30, 2026 Adopt Scheme Mandate Limit Compensation Board AGAINST 2
Kingsoft Cloud Holdings Limited June 30, 2026 Adopt Service Provider Sublimit Compensation Board AGAINST 2
Kingsoft Cloud Holdings Limited June 30, 2026 Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure Board AGAINST 2
Kingsoft Cloud Holdings Limited June 30, 2026 Authorize Reissuance of Repurchased Shares Capital Structure Board AGAINST 2
Lifco AB April 24, 2026 Approve Remuneration Report Compensation Board AGAINST 2
Lifco AB April 24, 2026 Reelect Carl Bennet as Board Chair Director Elections Board AGAINST 2
Lifco AB April 24, 2026 Reelect Carl Bennet as Director Director Elections Board AGAINST 2
Lifco AB April 24, 2026 Reelect Dan Frohm as Director Director Elections Board AGAINST 2
Lifco AB April 24, 2026 Reelect Erik Gabrielson as Director Director Elections Board AGAINST 2
Lotus Bakeries NV May 12, 2026 Approve Remuneration Report Compensation Board AGAINST 2
Lotus Bakeries NV May 12, 2026 Reelect PMF NV, Permanently Represented by Emanuel Boone, as Director Director Elections Board AGAINST 2
Merus N.V. December 9, 2025 Appointment of Anthony Pagano as non-executive director of Merus Director Elections Board AGAINST 2
Merus N.V. December 9, 2025 Appointment of Greg Mueller as non-executive director of Merus Director Elections Board AGAINST 2
Merus N.V. December 9, 2025 Appointment of Martine van Vugt, Ph.D., as non-executive director of Merus Director Elections Board AGAINST 2
Merus N.V. December 9, 2025 Non-binding advisory proposal to approve certain compensation arrangements Say-on-Pay Board AGAINST 2
MongoDB, Inc. June 30, 2026 Election of three Class III directors, each to serve until our Annual Meeting of Stockholders in 2029: Archana Agrawal Director Elections Board WITHHOLD 2
Natera, Inc. June 11, 2026 To approve an amendment to Natera's 2015 Equity Incentive Plan, as amended and restated. Compensation Board AGAINST 2
Nemetschek SE May 21, 2026 Approve Management Board Remuneration Policy Compensation Board AGAINST 2
Nemetschek SE May 21, 2026 Approve Remuneration Report Compensation Board AGAINST 2
Novo Nordisk A/S March 26, 2026 Reelect Britt Meelby Jensen as Director Director Elections Board ABSTAIN 2
Novo Nordisk A/S March 26, 2026 Reelect Kasim Kutay as Director Director Elections Board ABSTAIN 2
Novo Nordisk A/S March 26, 2026 Reelect Lars Rebien Sorensen (Chair) as Director Director Elections Board ABSTAIN 2
PT Telkom Indonesia (Persero) Tbk September 3, 2025 Approve Changes in the Boards of the Company Director Elections Board AGAINST 2
PT Telkom Indonesia (Persero) Tbk June 8, 2026 Approve Changes in the Boards of the Company Director Elections Board AGAINST 2
Pony AI Inc. June 8, 2026 Approve Deloitte Touche Tohmatsu Certified Public Accountants LLP and Deloitte Touche Tohmatsu as Auditors and Authorize Board to Fix Their Remuneration Audit-related Board AGAINST 2
Pony AI Inc. June 8, 2026 Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure Board AGAINST 2
Pony AI Inc. June 8, 2026 Authorize Reissuance of Repurchased Shares Capital Structure Board AGAINST 2
Recordati SpA April 29, 2026 Approve Second Section of the Remuneration Report Compensation Board AGAINST 2
Rocket Companies, Inc. June 10, 2026 Election of Class III Directors: Matthew Rizik Director Elections Board WITHHOLD 2
Rocket Companies, Inc. June 10, 2026 Election of Class III Directors: Suzanne Shank Director Elections Board WITHHOLD 2
Rocket Companies, Inc. June 10, 2026 Election of Class III Directors: Varun Krishna Director Elections Board WITHHOLD 2
StandardAero, Inc. June 25, 2026 Election of Class II Directors to serve until the 2029 Annual Meeting of Stockholder, and until their respective successors shall have been duly elected and qualified: Douglas V. Brandely Director Elections Board WITHHOLD 2
Swiss Life Holding AG May 7, 2026 Elect Patrick Frost as Director Director Elections Board AGAINST 2
Swiss Life Holding AG May 7, 2026 Ratify PricewaterhouseCoopers AG as Auditors Audit-related Board AGAINST 2
Swiss Life Holding AG May 7, 2026 Reappoint Klaus Tschuetscher as Member of the Compensation Committee Director Elections Board AGAINST 2
Swiss Life Holding AG May 7, 2026 Reappoint Martin Schmid as Member of the Compensation Committee Director Elections Board AGAINST 2
Swiss Life Holding AG May 7, 2026 Reelect Damir Filipovic as Director Director Elections Board AGAINST 2
Swiss Life Holding AG May 7, 2026 Reelect Franziska Sauber as Director Director Elections Board AGAINST 2
Swiss Life Holding AG May 7, 2026 Reelect Klaus Tschuetscher as Director Director Elections Board AGAINST 2
Swiss Life Holding AG May 7, 2026 Reelect Rolf Doerig as Director and Board Chair Director Elections Board AGAINST 2
Swiss Life Holding AG May 7, 2026 Reelect Thomas Buess as Director Director Elections Board AGAINST 2
Telenor ASA May 19, 2026 Approve Equity Plan Financing Through Repurchase of Shares Compensation Board AGAINST 2
Telenor ASA May 19, 2026 Approve Remuneration Statement (Advisory Vote) Compensation Board AGAINST 2
Tencent Holdings Limited May 13, 2026 Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure Board AGAINST 2
Tencent Holdings Limited May 13, 2026 Approve PricewaterhouseCoopers as Auditors and Authorize Board to Fix Their Remuneration Audit-related Board AGAINST 2
Viking Therapeutics, Inc. May 19, 2026 ELECTION OF DIRECTOR NOMINEES FOR CLASS II (term to expire in 2029): J. Matthew Singleton Director Elections Board WITHHOLD 2
Viking Therapeutics, Inc. May 19, 2026 ELECTION OF DIRECTOR NOMINEES FOR CLASS II (term to expire in 2029): S. Kathryn Rouan, Ph.D. Director Elections Board WITHHOLD 2
Viking Therapeutics, Inc. May 19, 2026 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. Say-on-Pay Board AGAINST 2
Viper Energy, Inc. May 19, 2026 The approval, on an advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay Board AGAINST 2
Wayfair Inc. May 21, 2026 A non-binding advisory resolution to approve executive compensation. Say-on-Pay Board AGAINST 2
Wayfair Inc. May 21, 2026 Election of Nine Directors: Diana Frost Director Elections Board ABSTAIN 2
Wayfair Inc. May 21, 2026 Election of Nine Directors: Jeremy King Director Elections Board ABSTAIN 2
Wayfair Inc. May 21, 2026 Election of Nine Directors: Michael Kumin Director Elections Board ABSTAIN 2
Wayfair Inc. May 21, 2026 To approve Amendment No. 1 to the Wayfair Inc. 2023 Incentive Award Plan. Compensation Board AGAINST 2
X4 Pharmaceuticals, Inc. May 11, 2026 Election of Class III Directors for terms expiring in 2029: Francoise De Craecker Director Elections Board WITHHOLD 2
X4 Pharmaceuticals, Inc. May 11, 2026 Election of Class III Directors for terms expiring in 2029: Gary J. Bridger, Ph.D. Director Elections Board WITHHOLD 2
X4 Pharmaceuticals, Inc. May 11, 2026 Election of Class III Directors for terms expiring in 2029: Murray W. Stewart, M.D. Director Elections Board WITHHOLD 2
X4 Pharmaceuticals, Inc. May 11, 2026 To approve the second amendment and restatement of the X4 Pharmaceuticals, Inc. 2017 Equity Incentive Plan, increasing the number of shares available for issuance under the plan. Compensation Board AGAINST 2
X4 Pharmaceuticals, Inc. May 11, 2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. Say-on-Pay Board AGAINST 2
Zai Lab Limited June 17, 2026 THAT, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved. Say-on-Pay Board AGAINST 2
AC Immune SA June 11, 2026 Approve Creation of CHF 150,000 Pool of Conditional Capital for Employee Equity Plans Compensation Board AGAINST 1
AC Immune SA June 11, 2026 Approve Creation of Capital Band within the Upper Limit of CHF 2.9 Million and the Lower Limit of CHF 2.2 Million with or without Exclusion of Preemptive Rights Capital Structure Board AGAINST 1
AC Immune SA June 11, 2026 Approve Remuneration Report (Non-Binding) Compensation Board AGAINST 1
AC Immune SA June 11, 2026 Approve Remuneration of Directors in the Amount of CHF 1 Million Compensation Board AGAINST 1
AST Spacemobile, Inc. June 12, 2026 To approve the non-binding advisory resolution on the compensation paid to the Company's named executive officers. Say-on-Pay Board AGAINST 1
Abivax SA May 11, 2026 Approve Compensation Report Compensation Board AGAINST 1
Abivax SA May 11, 2026 Approve Compensation Report of Corporate Officers Compensation Board AGAINST 1
Abivax SA May 11, 2026 Approve Compensation of Marc de Garidel, CEO Say-on-Pay Board AGAINST 1
Abivax SA May 11, 2026 Approve Compensation of Sylvie Gregoire, Chairwoman of the Board Say-on-Pay Board AGAINST 1
Abivax SA May 11, 2026 Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries, up to Aggregate Nominal Amount of EUR 750,000 Capital Structure Board AGAINST 1
Abivax SA May 11, 2026 Approve Issuance of Equity or Equity-Linked Securities for Qualified Investors, up to Aggregate Nominal Amount of EUR 237,873.56 Capital Structure Board AGAINST 1
Abivax SA May 11, 2026 Approve Issuance of Warrants (Bons) Reserved for Services Providers, Consultants, Employees and Executives, up to 10 Percent of Issued Share Capital Compensation Board AGAINST 1
Abivax SA May 11, 2026 Approve Remuneration Policy of CEO Compensation Board AGAINST 1
Abivax SA May 11, 2026 Approve Remuneration Policy of Chairwoman of the Board Compensation Board AGAINST 1
Abivax SA May 11, 2026 Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above Capital Structure Board AGAINST 1
Abivax SA May 11, 2026 Authorize Capital Increase of Up to EUR 750,000 for Future Exchange Offers Capital Structure Board AGAINST 1
Abivax SA May 11, 2026 Authorize Capital Increase of up to 20 Percent of Issued Capital for Contributions in Kind Capital Structure Board AGAINST 1
Abivax SA May 11, 2026 Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000 Capital Structure Board AGAINST 1
Abivax SA May 11, 2026 Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000 Capital Structure Board AGAINST 1
Abivax SA May 11, 2026 Authorize Repurchase of Up to 10 Percent of Issued Share Capital Capital Structure Board AGAINST 1
Abivax SA May 11, 2026 Authorize up to 10 Percent of Issued Capital for Use in Restricted Stock Plans Compensation Board AGAINST 1
Abivax SA May 11, 2026 Authorize up to 10 Percent of Issued Capital for Use in Stock Option Plans Compensation Board AGAINST 1
Abivax SA May 11, 2026 Reelect June Lee as Director Director Elections Board AGAINST 1
Abivax SA May 11, 2026 Reelect Sylvie Gregoire as Director Director Elections Board AGAINST 1
Abivax SA May 11, 2026 Reelect Troy Ignelzi as Director Director Elections Board AGAINST 1
Acea SpA June 3, 2026 Approve Second Section of the Remuneration Report Compensation Board AGAINST 1
Aena S.M.E. SA April 16, 2026 Reelect Maurici Lucena Betriu as Director Director Elections Board AGAINST 1
Aeroports de Paris May 21, 2026 Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to Aggregate Nominal Amount of EUR 29 Million Capital Structure Board AGAINST 1
Aeroports de Paris May 21, 2026 Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 19, 20 and 21 Capital Structure Board AGAINST 1
Aeroports de Paris May 21, 2026 Authorize Capital Increase of Up to EUR 29 Million for Future Exchange Offers Capital Structure Board AGAINST 1

← Previous Page 24 of 29 Next →

← Back to ProShares 2025-2026 overview

Built November 1, 2026 from SEC Form N-PX filings.